Today: 9 June 2026
Browse Category

NASDAQ:MLTX 29 September 2025 - 8 January 2026

Biotech Bombshell: MoonLake (MLTX) Shares Tumble 85% on Trial News – Is a $108 Price Target Still Real?

Biotech Bombshell: MoonLake (MLTX) Shares Tumble 85% on Trial News – Is a $108 Price Target Still Real?

MoonLake Immunotherapeutics shares plunged about 85% pre-market Monday after mixed Phase 3 VELA trial results, dropping from around $62 to under $8 and cutting market cap from $3.9 billion to $0.5 billion. The stock had surged days earlier on takeover rumors and clinical optimism. VELA-1 met its primary endpoint, but VELA-2 narrowly missed. Analyst sentiment turned sharply negative after the data release.
29 September 2025
·

Stock Market Today

  • Crude Oil Prices Plunge on US-Iran Peace Hopes Amid Mixed Supply and Demand Signals
    June 9, 2026, 5:28 PM EDT. Crude oil prices tumbled to a 7-week low on Tuesday, falling 3.4% as ceasefire optimism between the US and Iran raised hopes for easing tensions and reopening the Strait of Hormuz, a key oil transit chokepoint. Gasoline prices hit an 8-week low, down 1.61%. President Trump signaled a potential rapid end to hostilities, which weighed on prices, while Chinese crude imports fell to an eight-year low, reducing demand. However, fears resurfaced when the US blamed Iran for downing a military helicopter, threatening the fragile peace. On supply, the US Energy Department raised its 2026 output forecast, pressuring prices, but ongoing Ukrainian drone attacks have disrupted Russian oil infrastructure, tightening global supplies. The International Energy Agency warned of a severely undersupplied oil market through October despite these developments.

Latest articles

Epsium Enterprise Shares Surge 72% in Volatile Nasdaq Trading

Epsium Enterprise Shares Surge 72% in Volatile Nasdaq Trading

9 June 2026
Epsium Enterprise soared 72.27% to close at $2.05 on record volume over 65 million shares—more than 200 times its average—before dropping 18.54% after hours to $1.67, as traders piled into the volatile Macau beverage wholesaler despite no major news and fundamentals showing falling revenue and a net loss.
Why Hims & Hers Stock Jumped Today as Its Weight-Loss Bet Gets a Second Look

Why Hims & Hers Stock Jumped Today as Its Weight-Loss Bet Gets a Second Look

9 June 2026
Hims & Hers Health surged 6.6% to $28.98 Tuesday on heavy volume, bucking a tech selloff as investors bet on its ability to profitably scale weight-loss drug sales after a tough quarter marked by missed revenue, a surprise loss, and margin pressure from branded GLP-1s, with new international expansion and Eucalyptus acquisition in focus.
RBC Stock Hits 52-Week High Even as TSX Falls

RBC Stock Hits 52-Week High Even as TSX Falls

9 June 2026
Royal Bank of Canada surged to a new 52-week high at C$277.09 before closing up 1.24% at C$276.01, outpacing the S&P/TSX’s 0.2% drop, after reporting Q2 net income of C$5.5 billion and adjusted EPS of C$3.90, beating estimates. Despite strong results and a 58.61% year-over-year gain, risks remain as the market is not cheap and investors await the Bank of Canada’s rate decision.
BigBear.ai Stock Drops as Panama AI Buzz Runs Into Dilution Worries

BigBear.ai Stock Drops as Panama AI Buzz Runs Into Dilution Worries

9 June 2026
BigBear.ai shares fell 33 cents to $3.98 as investors weighed a Panama cargo-security deployment, annual meeting results, and the company’s ongoing losses; despite a 14% backlog jump and $431.5 million in cash, revenue conversion remains uncertain, and a recent increase in authorized shares raises dilution risks.
Go toTop